Imagin Medical Inc. (IMEXF)

[IMeasy]

New poster here. I own IMEXF as a buy out play @ average 21 cents a share. The main risks to my investment: 1) Dilution: the only way this company can operate without earned revenue is to continually release special shares, this will lead to dilution of average share value. 2) Delay: that it might take so long to release the test results that interest will die. 3) Demand: that the process may not present enough advantage for the market to adapt this technology resulting in no or low buyout bids. 4) Dumbness if the buyout offer is to low and management decides to rollout and distribute the product. If no one else is willing to buy this technology pre release, then maybe there is nothing here. My personal goal is for a $3.50 buyout by mid 2019, but if there are multiple parties bidding, especially if they are from outside this tiny segment, then it could get interesting.